2. Academic Validation
  3. CGP 35949, an LTD4 antagonist with phospholipase inhibitory activity: a new approach to the treatment of asthma

CGP 35949, an LTD4 antagonist with phospholipase inhibitory activity: a new approach to the treatment of asthma

  • Adv Prostaglandin Thromboxane Leukot Res. 1987;17B:771-4.
A Beck 1,  A Sallmann,  P Wenk,  F Märki,  M A Bray
Affiliations

Affiliation

  • 1 Research Department, CIBA-GEIGY Ltd., Basle, Switzerland.
PMID: 2960189
Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z